Menlo Therapeutics
Why Robinhood?
You can watch MNLO and buy or sell other stocks, ETFs, and their options commission-free!About MNLO
Menlo Therapeutics is a clinical late-stage biopharmaceutical company focused on the development and commercialization of serlopitant for the treatment of pruritus (itch) associated with dermatologic conditions such as atopic dermatitis, psoriasis and prurigo nodularis. We are concurrently evaluating the use of serlopitant for refractory chronic cough, a cough that persists for greater than eight weeks despite treatment of any identified underlying cause.
MNLO Key Statistics
Stock Snapshot
Menlo Therapeutics(MNLO) stock is priced at $3.50, giving the company a market capitalization of 116.63M. It carries a P/E multiple of -0.91.
During the trading day, Menlo Therapeutics(MNLO) stock saw an opening price of —, a peak of —, and a bottom of —.
Trading volume for Menlo Therapeutics(MNLO) stock has reached 0, versus its average volume of 189.32K.
Over the past 52 weeks, Menlo Therapeutics(MNLO) stock has traded between a high of $1.99 and a low of $0.28.
Over the past 52 weeks, Menlo Therapeutics(MNLO) stock has traded between a high of $1.99 and a low of $0.28.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.